等待开盘 10-08 09:30:00 美东时间
+0.030
+0.68%
今日重点评级关注:Jones Trading:维持Opus Genetics"买入"评级,目标价从10美元升至17美元;Citizens:维持Rezolute"跑赢大市"评级,目标价从11美元升至15美元
10-07 17:30
Jones Trading maintains Opus Genetics (NASDAQ:IRD) with a Buy and raises the price target from $10 to $17.
10-07 03:03
A group of U.S. small-cap stocks is flashing A+ momentum grades in the latest quantitative screen, with several names posting triple-digit gains year to date. Seeking Alpha's Quant Momentum Grade meas...
09-17 21:55
今日重点评级关注:康托·菲茨杰拉德:维持SOL Strategies"超配"评级,目标价从2.8美元升至6.2美元;康托·菲茨杰拉德:维持Sui Group Holdings"超配"评级,目标价从1.7美元升至3.4美元
09-11 14:30
今日重点评级关注:富国银行:维持Pyxis Oncology"超配"评级,目标价从12美元升至19美元;Oppenheimer:维持Opus Genetics"跑赢大市"评级,目标价从10美元升至20美元
09-10 15:00
业绩股齐升!西格内特珠宝劲升24%,Q2盈利超预期26%;Academy、Flotek均升逾14%,双双上调业绩指引>>
09-10 19:16
U.S. stocks were lower, with the Dow Jones index falling around 400 points on Wednesday. Shares of Caleres Inc (NYSE:CAL) rose sharply after the company reported better-than-expected second-quarter financial results and raised its FY26 EPS guidance. Caleres reported quarterly earnings of 47 cents pe...
09-09 22:04
Opus Genetics ( ($IRD) ) just unveiled an announcement. On September 9, 2026, O...
09-09 19:59
云米科技狂飙逾83%,AI净水战略点燃市场;GoPro三日累升超180%,大股东入局+跨界AI光器件;戴尔劲升近16%,AI服务器订单积压达950亿美元>>
09-03 18:57
Topline data from Phase 1/2 Cohort 1 of OPGx-BEST1 gene therapy program to be presented during investor conference call and webcast on September 9 at 8:00 a.m. ET Full clinical dataset and additional analyses evaluating key measures of visual function to be presented at upcoming medical meetings RES...
09-02 19:07